Notice of Intent to Publish Reissuance of RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)"

Notice Number: NOT-OD-19-130

Key Dates

Release Date: August 15, 2019
Estimated Publication Date of Funding Opportunity Announcement: August 28, 2019
First Estimated Application Due Date: February 13, 2020
Earliest Estimated Award Date: August 11, 2020
Earliest Estimated Start Date: September 11, 2020

Related Announcements

Issued by
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)


This Notice is to inform the research community that the National Institutes of Health (NIH) Tobacco Regulatory Science Program (TRSP), participating NIH Institutes, and the United States Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intend to reissue the Funding Opportunity Announcement (FOA) RFA-OD-19-019 "Tobacco Regulatory Science (R01 Clinical Trial Optional)." When reissued, this FOA will continue to utilize the R01 grant mechanism. Modifications to this FOA will be the inclusion of new and revised research priorities. This Notice is being published now to inform prospective applicants in advance of this modification. The FOA is expected to be published in Summer 2019.

Research Initiative Details

The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.

Funding Information

Estimated Total Funding NIH, via support from the FDA Center for Tobacco products (CTP), intends to fund up to 8 R01s, corresponding to a total of up to $4 million, for fiscal year 2020. Future year amounts will depend on availability of funds.
Expected Number of Awards 8
Estimated Award Ceiling Application budgets are limited to $300,000 in direct cost per year for up to three years.
Primary CFDA Numbers 93.077

Anticipated Eligible Organizations

Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time.


Please direct all inquiries to:

Tobacco Regulatory Science Program
Office of Disease Prevention